Canine atopic dermatitis is one of the most common and welfare-impactful conditions in dogs, causing persistent itch, skin damage and significant distress that requires long-term multimodal management.
The welfare impact of canine atopic dermatitis is frequently underestimated by owners who view scratching as a minor inconvenience. Validated itch scoring tools and owner-reported quality of life measures consistently reveal that moderate-to-severe CAD causes significant, persistent suffering. Pruritus is neurologically aversive — chronic itch is among the most difficult sensations to habituate to, causing sleep disruption, anxiety, frustration and behavioural changes. Dogs that scratch and chew compulsively often damage their skin to the point of open wounds, creating painful secondary infections and the vicious cycle of itch-scratch-infection-itch. The emotional and relational impact extends to owners: the guilt of watching a dog in persistent discomfort and the cost and complexity of long-term management cause significant owner distress. Undertreated CAD also causes owner-dog relationship deterioration as scratching becomes disruptive to daily life. Modern biologics like Cytopoint have transformed welfare outcomes but remain expensive and require long-term commitment.